Collexis Announces BiomedExperts Hosts More Than 30,000
Registered Users Worldwide
Thursday, July 31, 2008 – Collexis Holdings Inc. (OTCBB: CLXS), a leading developer of semantic search and knowledge discovery software, announced today that its premier professional scientific social networking site, Biomedexperts.com, has more than 30,000 registered users, enabling researchers across organizations and around the globe to collaborate more efficiently and effectively.
In April Collexis implemented the first phase of their marketing campaign and since that time BiomedExperts’ user registrations have skyrocketed from 2,000 to more than 30,000. BiomedExperts.com is a collaborative agreement with Dell Healthcare and Life Sciences. Through this initiative, Dell is providing the hardware and continued marketing support for the site and Collexis is contributing knowledge discovery and text mining applications.
“The success of BiomedExperts.com is a testament to the role innovative technology can play in enabling researchers to collaborate and drive meaningful scientific discoveries,” said James Coffin, Ph.D., vice president and general manager, Dell Health Care and Life Sciences. “The possibilities are tremendous when scientists of varying disciplines work together on a similar goal, and in this connected era bringing research communities together through technology can have real and significant impact on scientific discoveries and ultimately patient care.”
Pre-populated with over 1.5 million Pub-Med-based expert profiles, BiomedExperts allows scientists and
researchers to directly connect with and explore their own professional contacts, grow their networks and
identify researchers with the expertise needed for future collaborations. Through user-friendly search
interfaces, potential research collaborators can share data and collaborate with professionals from more
than 1,800 organizations and institutions from 137 countries, totaling more than 21 million connections
made through the site.
Read the full press release here.